The DOI matches its OpenAlex record; 76 of the 76 references it cites were found in a registry or an index.
The enigma of sepsis
Open accessAbstract
Sepsis remains a serious cause of morbidity and mortality, and the pathophysiology of the disease is not clear. The definition of the clinical manifestations of sepsis is ever evolving. This review discusses the search for effective therapeutic interventions, hurdles in translational sepsis research, and new therapies in development in current clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448 · cited 1×
“found that TNF-α blockade was beneficial in animal models of shock following infusion of endotoxin or Escherichia coli (17, 18).”
Beutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
Detection of circulating tumor necrosis factor after endotoxin administration
Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677 · cited 1×
“462 The Journal of Clinical Investigation | August 2003 | Volume 112 | Number 4 characteristic of sepsis (14), while passive immunization with anti–TNF-αwas protective (15, 16).”
High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial
Warren, B. L., Eid, A., Singer, P., Pillay, S. S., Carl, P., Novak, I., Chalupa, P., Atherstone, A., Pénzes, I., Kübler, A., et al. (2001) · JAMA · doi:10.1001/jama.286.15.1869 · Cited by 1,419
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
Multiple-Organ Failure: Generalized Autodestructive Inflammation?
Goris, R. J. A. (1985) · Archives of Surgery · doi:10.1001/archsurg.1985.01390340007001 · Cited by 1,289
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H., & Benjamin, E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342603 · Cited by 1,241
MIF as a glucocorticoid-induced modulator of cytokine production
Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T., Cerami, A., & Bucala, R. (1995) · Nature · doi:10.1038/377068a0 · Cited by 1,149
Sacks, T., Moldow, C. F., Craddock, P. R., Bowers, T. K., & Jacob, H. S. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109031 · Cited by 1,103
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A., & Bucala, R. (1993) · Nature · doi:10.1038/365756a0 · Cited by 999
Calandra, T., Bernhagen, J., Mitchell, R. A., & Bucala, R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.6.1895 · Cited by 985
Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway
Riewald, M., Petrovan, R. J., Donner, A., Mueller, B. M., & Ruf, W. (2002) · Science · doi:10.1126/science.1071699 · Cited by 831
(1999) · Burn Care · doi:10.1201/9781498713979-15 · Cited by 819
Novel strategies for the treatment of sepsis
Riedemann, N. C., Guo, R.-F., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 773
Self-citationTumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious Purpura
Girardin, E., Grau, G. E., Dayer, J.-M., Roux-Lombard, P., the J5 Study Group*, & Lambert, P.-H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190703 · Cited by 737
Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells
Fiuza, C., Bustin, M., Talwar, S., Tropea, M., Gerstenberger, E., Shelhamer, J. H., & Suffredini, A. F. (2003) · Blood · doi:10.1182/blood-2002-05-1300 · Cited by 737
Protection from septic shock by neutralization of macrophage migration inhibitory factor
Calandra, T., Echtenacher, B., Roy, D. L., Pugin, J., Metz, C. N., Hültner, L., Heumann, D., Männel, D., Bucala, R., & Glauser, M. P. (2000) · Nature Medicine · doi:10.1038/72262 · Cited by 723
Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.
Bone, R. C., Fisher, C. J., Clemmer, T. P., Gj, S., METZ, C. A., & BALK, R. A. (1989) · PubMed · Cited by 689
Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation
Ulloa, L., Ochani, M., Yang, H., Tanovic, M., Halperin, D., Yang, R., Czura, C. J., Fink, M. P., & Tracey, K. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192222999 · Cited by 585
Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis
Bozza, M., Satoskar, A. R., Lin, G., Lu, B., Humbles, A. A., Gerard, C., & David, J. R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.341 · Cited by 551
Sepsis syndrome: A valid clinical entity
BONE, R. C., FISHER, C. J., CLEMMER, T. P., SLOTMAN, G. J., METZ, C. A., & BALK, R. A. (1989) · Critical Care Medicine · doi:10.1097/00003246-198905000-00002 · Cited by 537
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte
Hotchkiss, R. S., Chang, K. C., Swanson, P. E., Tinsley, K. W., Hui, J. J., Klender, P., Xanthoudakis, S., Roy, S., Black, C., Grimm, E., et al. (2000) · Nature Immunology · doi:10.1038/82741 · Cited by 526
HMGB1 as a Late Mediator of Lethal Systemic Inflammation
WANG, H., YANG, H., CZURA, C. J., SAMA, A. E., & TRACEY, K. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2106117 · Cited by 490
Prevention of lymphocyte cell death in sepsis improves survival in mice
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Chang, K. C., Cobb, J. P., Buchman, T. G., Korsmeyer, S. J., & Karl, I. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14541 · Cited by 454
Protective effects of C5a blockade in sepsis
Czermak, B. J., Sarma, V., Pierson, C. L., Warner, R. L., Huber-Lang, M., Bless, N. M., Schmal, H., Friedl, H. P., & Ward, P. A. (1999) · Nature Medicine · doi:10.1038/10512 · Cited by 404
Self-citationAnnane, D., Sebille, V., & Charpentier, C. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00997-2 · Cited by 382
Overexpression of Bcl-2 in Transgenic Mice Decreases Apoptosis and Improves Survival in Sepsis
Hotchkiss, R. S., Swanson, P. E., Knudson, C. M., Chang, K. C., Cobb, J. P., Osborne, D. F., Zollner, K. M., Buchman, T. G., Korsmeyer, S. J., & Karl, I. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4148 · Cited by 381
Definitions for sepsis and organ failure
Bone, R. C. (1992) · Critical Care Medicine · doi:10.1097/00003246-199206000-00002 · Cited by 360
Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings
(1989) · Journal of Critical Care · doi:10.1016/0883-9441(89)90142-1 · Cited by 357
Risk and the Efficacy of Antiinflammatory Agents: Retrospective and Confirmatory Studies of Sepsis
Eichacker, P. Q., Parent, C., Kalil, A., Esposito, C., Cui, X., Banks, S. M., Gerstenberger, E. P., Fitz, Y., Danner, R. L., & Natanson, C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-302oc · Cited by 341
Eskandari, M. K., Bolgos, G., Miller, C., Nguyen, D. T., DeForge, L. E., & Remick, D. G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.9.2724 · Cited by 323
Sappington, P. L., Yang, R., Yang, H., Tracey, K. J., Delude, R. L., & Fink, M. P. (2002) · Gastroenterology · doi:10.1053/gast.2002.35391 · Cited by 320
Coopersmith, C. M. (2002) · JAMA · doi:10.1001/jama.287.13.1716 · Cited by 298
Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned
Reinhart, K., & Karzai, W. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00037 · Cited by 288
Chemotactic and Anaphylatoxic Fragment Cleaved from the Fifth Component of Guinea Pig Complement
Shin, H. S., Snyderman, R., Friedman, E., Mellors, A., & Mayer, M. M. (1968) · Science · doi:10.1126/science.162.3851.361 · Cited by 281
Apoptosis in sepsis: a new target for therapeutic exploration
OBERHOLZER, C., OBERHOLZER, A., CLARE-SALZLER, M., & MOLDAWER, L. L. (2001) · The FASEB Journal · doi:10.1096/fj.00-058rev · Cited by 271
Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates.
Stevens, J. H., O'Hanley, P. D., Shapiro, J., Mihm, F. G., Satoh, P. S., Collins, J. A., & Raffin, T. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112506 · Cited by 267
An Economic Evaluation of Activated Protein C Treatment for Severe Sepsis
Manns, B. J., Lee, H., Doig, C. J., Johnson, D., & Donaldson, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa020969 · Cited by 234
Rossi, A. G., Haslett, C., Hirani, N., Greening, A. P., Rahman, I., Metz, C. N., Bucala, R., & Donnelly, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1524 · Cited by 218
Complement-Induced Impairment of Innate Immunity During Sepsis
Huber-Lang, M. S., Younkin, E. M., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Curnutte, J. T., Erickson, R., & Ward, P. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3223 · Cited by 200
Self-citationGeneration of C5-Derived Lysosomal Enzyme-Releasing Activity (C5a) by Lysates of Leukocyte Lysosomes
Goldstein, I. M., & Weissmann, G. (1974) · The Journal of Immunology · doi:10.4049/jimmunol.113.5.1583 · Cited by 194
Whole-Body Inflammation in Trauma Patients: An Autopsy Study
Nuytinck, H. K. S. (1988) · Archives of Surgery · doi:10.1001/archsurg.1988.01400360089016 · Cited by 190
Increased C5a receptor expression in sepsis
Riedemann, N. C., Guo, R., Neff, T. A., Laudes, I. J., Keller, K. A., Sarma, V. J., Markiewski, M. M., Mastellos, D. C., Strey, C. W., Pierson, C. L., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15409 · Cited by 190
Self-citationHotchkiss, R. S., Chang, K. C., Grayson, M. H., Tinsley, K. W., Dunne, B. S., Davis, C. G., Osborne, D. F., & Karl, I. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031788100 · Cited by 181
Anti-C5a Ameliorates Coagulation/Fibrinolytic Protein Changes in a Rat Model of Sepsis
Laudes, I. J., Chu, J. C., Sikranth, S., Huber-Lang, M., Guo, R.-F., Riedemann, N., Sarma, J. V., Schmaier, A. H., & Ward, P. A. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61133-9 · Cited by 165
Self-citationOverexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice
Coopersmith, C. M., Chang, K. C., Swanson, P. E., Tinsley, K. W., Stromberg, P. E., Buchman, T. G., Karl, I. E., & Hotchkiss, R. S. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201000-00028 · Cited by 162
Protection of innate immunity by C5aR antagonist in septic mice
Huber‐Lang, M. S., Riedeman, N. C., Sarma, J. V., Younkin, E. M., McGuire, S. R., Laudes, I. J., Lu, K. T., Guo, R., Neff, T. A., Padgaonkar, V. A., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0209com · Cited by 161
Self-citationIncreased C5a receptor expression in sepsis
Riedemann, N. C., Guo, R., Neff, T. A., Laudes, I. J., Keller, K. A., Sarma, V. J., Markiewski, M. M., Mastellos, D. C., Strey, C. W., Pierson, C. L., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215409 · Cited by 157
Self-citationProtective effects of anti-C5a in sepsis-induced thymocyte apoptosis
Guo, R., Huber-Lang, M. S., Wang, X., Sarma, V. J., Padgaonkar, V. A., Craig, R. A., Riedemann, N. C., McClintock, S. D., Hlaing, T., Shi, M. M., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10793 · Cited by 152
Self-citationRegulation by C5a of Neutrophil Activation during Sepsis
Riedemann, N. C., Guo, R., Bernacki, K. D., Reuben, J. S., Laudes, I. J., Neff, T. A., Gao, H., Speyer, C. L., Sarma, V. J., Zetoune, F. S., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00206-1 · Cited by 121
Self-citationPlasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis
Lehmann, L. E., Novender, U., Schroeder, S., Pietsch, T., von Spiegel, T., Putensen, C., Hoeft, A., & Stüber, F. (2001) · Intensive Care Medicine · doi:10.1007/s001340101022 · Cited by 106
Thomas, L. (1972) · New England Journal of Medicine · doi:10.1056/nejm197209142871109 · Cited by 96
Arndt, U., Wennemuth, G., Barth, P. J., Nain, M., Al‐Abed, Y., Meinhardt, A., Gemsa, D., & Bacher, M. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9298-9306.2002 · Cited by 95
ANTIBIOTIC TREATMENT INFLUENCES OUTCOME IN MURINE SEPSIS
Newcomb, D. E., Bolgos, G. L., Green, L. B., & Remick, D. G. (1998) · Shock · doi:10.1097/00024382-199808000-00005 · Cited by 92
Anaphylatoxin Formation in Sepsis
Bengtson, A., & Heideman, M. (1988) · Archives of Surgery · doi:10.1001/archsurg.1988.01400290131023 · Cited by 88
C5a receptor and thymocyte apoptosis in sepsis
Riedemann, N. C., Guo, R., Laudes, I. J., Keller, K. A., Sarma, V. J., Padgaonkar, V. A., Zetoune, F. S., & Ward, P. A. (2002) · The FASEB Journal · doi:10.1096/fj.02-0033fje · Cited by 86
Self-citationNeutrophil C5a receptor and the outcome in a rat model of sepsis
Guo, R., Riedemann, N. C., Bernacki, K. D., Sarma, V. J., Laudes, I. J., Reuben, J. S., Younkin, E. M., Neff, T. A., Paulauskis, J. D., Zetoune, F. S., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0009fje · Cited by 84
Self-citationChronological changes in the complement system in sepsis
Nakae, H., Endo, S., Inada, K., & Yoshida, M. (1996) · Surgery Today · doi:10.1007/bf00311579 · Cited by 75
Adjunctive therapy in sepsis: a critical analysis of the clinical trial programme
Cohen, J. (1999) · British Medical Bulletin · doi:10.1258/0007142991902222 · Cited by 71
Schumacher, W. A., Fantone, J. C., Kunkel, S. L., Webb, R. C., & Lucchesi, B. R. (1991) · Inflammation Research · doi:10.1007/bf01988727 · Cited by 68
Serum complement levels and severity of sepsis.
Nakae, H., Endo, S., Inada, K., Takakuwa, T., Kasai, T., & Yoshida, M. (1994) · PubMed · Cited by 64
Gando, S., Nishihira, J., Kobayashi, S., Morimoto, Y., Nanzaki, S., & Kemmotsu, O. (2001) · Intensive Care Medicine · doi:10.1007/s001340000818 · Cited by 60
New and Emerging Therapies for Sepsis
Healy, D. P. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a283 · Cited by 46
Anti-inflammatory strategies for the treatment of sepsis
Riedemann, N. C., & Ward, P. A. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.2.339 · Cited by 33
Self-citation
Cited by
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Acute Renal Failure and Sepsis
Schrier, R. W., & Wang, W. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032401 · Cited by 1,260
ROLE OF C5A IN INFLAMMATORY RESPONSES
Guo, R.-F., & Ward, P. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115835 · Cited by 1,021
Self-citation
Metadata
- Authors
- Riedemann, N. C., Guo, R., & Ward, P. A.
- Venue
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Published
- 2003-08-15
- Volume
- 112
- Issue
- 4
- Pages
- 460-467
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1976455881
- Cited by
- 624
- References
- 76
- FWCI
- 26.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.